Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04298060
What this trial is testing

DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)

Who this might be right for
Influenza InfectionSAD-RV Infection and COVID-19
Ansun Biopharma, Inc. 280
Testing effectiveness (Phase 2)Study completedNCT00170443
What this trial is testing

Trivalent rHA Dose Escalation Study in Elderly Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 399
Testing effectiveness (Phase 2)Study completedNCT05734040
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Who this might be right for
Influenza
Osivax 478
Testing effectiveness (Phase 2)Study completedNCT00776438
What this trial is testing

Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

Who this might be right for
InfluenzaOrthomyxovirus InfectionsMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 160
Not applicableStudy completedNCT02567721
What this trial is testing

Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)

Who this might be right for
Influenza
GlaxoSmithKline 11,530
Not applicableStudy completedNCT02334514
What this trial is testing

The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection

Who this might be right for
Influenza
Rambam Health Care Campus 215
Large-scale testing (Phase 3)Study completedNCT02214225
What this trial is testing

Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

Who this might be right for
Influenza, Human
Seqirus 3,484
Testing effectiveness (Phase 2)Study completedNCT05052697
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

Who this might be right for
Influenza, Human
Pfizer 1,158
Large-scale testing (Phase 3)Study completedNCT01439360
What this trial is testing

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Who this might be right for
Influenza
GlaxoSmithKline 12,046
Testing effectiveness (Phase 2)Study completedNCT03570359
What this trial is testing

Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Synairgen Research Ltd. 122
Post-approval studies (Phase 4)Study completedNCT01196026
What this trial is testing

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Who this might be right for
Influenza
GlaxoSmithKline 162
Large-scale testing (Phase 3)Study completedNCT01257243
What this trial is testing

Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment

Who this might be right for
Cough
EMS 260
Testing effectiveness (Phase 2)Study completedNCT01403376
What this trial is testing

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide

Who this might be right for
Multiple Sclerosis
Sanofi 128
Testing effectiveness (Phase 2)Study completedNCT01625689
What this trial is testing

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Who this might be right for
Influenza
PATH Vaccine Solutions 309
Early research (Phase 1)Looking for participantsNCT06753474
What this trial is testing

A/Texas Flu Challenge

Who this might be right for
Influenza
Emory University 50
Not applicableStudy completedNCT01302418
What this trial is testing

Collection and Testing of Respiratory Samples

Who this might be right for
QIAGEN ResPlex II Advanced PanelInfluenza ARespiratory Syncytial Virus Infections+15 more
QIAGEN Gaithersburg, Inc 272
Not applicableStudy completedNCT05568979
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 1,001
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Not applicableStudy completedNCT05220423
What this trial is testing

Effectiveness of SMS Reminders on Influenza Vaccination Coverage in Patients With RA in the ART Registry

Who this might be right for
Rheumatoid Arthritis
Societe Francaise de Rhumatologie 446
Not applicableUnknownNCT03010410
What this trial is testing

Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS)

Who this might be right for
SepsisInfluenza
Intermountain Health Care, Inc. 150
Next Page